TPV 250 (Aptivus 250 mg)

Generic Name: tipranavir

Pill imprint TPV 250 has been identified as Aptivus 250 mg.

Aptivus is used in the treatment of hiv infection and belongs to the drug class protease inhibitors. Risk cannot be ruled out during pregnancy. Aptivus 250 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for TPV 250

Aptivus 250 mg TPV 250
Aptivus
Generic Name:
tipranavir
Imprint:
TPV 250
Strength:
250 mg
Color:
Pink
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Protease inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Boehringer Ingelheim Pharmaceuticals, Inc.
National Drug Code (NDC):
00597-0003
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54569-5719 A S Medication Solutions LLC (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)